Peptides for Anti-Ageing: The Science of Collagen, Skin, and Joint Regeneration

Peptides are revolutionising how we approach skin rejuvenation, hair strengthening, and joint health. The benefits of these peptides for anti-ageing, such as human growth hormone (HGH), alongside innovative compounds like GHK-Cu, are rewriting the rules for how we approach ageing, both cosmetically and health-wise.

 

Human Growth Hormone

Human growth hormone, often called HGH, is known as the main molecule linked to fighting ageing. The anterior pituitary gland releases HGH, which is crucial to repair tissues, grow muscles, and regulate metabolism throughout life. (1) But as people age, the natural production of HGH drops. After turning 30, it reduces by around 14% every ten years.(2)

This drop connects with common signs of ageing like less elastic skin, lower muscle mass higher body fat, and weaker bones. HGH works against ageing by helping the liver produce insulin-like growth factor-1 or IGF-1. IGF-1 helps the body produce collagen, improve protein use, and renew cells.(3)

Studies show that taking HGH supplements boosts skin thickness by promoting fibroblast activity and helping the body make more collagen. This includes type I and type III collagen, which are the main kinds found in skin, tendons, and bones. (4) HGH also plays a key role in supporting joint health and keeping cartilage healthy because it increases the growth of chondrocytes. (5)

 

Growth Hormone Secretagogues

Rather than administering exogenous HGH, growth hormone secretagogues (GHS) offer an elegant alternative by stimulating the body’s endogenous production. These peptides work by binding to the growth hormone secretagogue receptor (GHS-R), also known as the ghrelin receptor, triggering a cascade that results in HGH release from the pituitary gland (6).

Ipamorelin and GHRP-6

Ipamorelin, which is a selective GHS, has gained more research attention in recent years for its ability to stimulate HGH release without significantly affecting cortisol or prolactin levels, giving it a distinct advantage over earlier secretagogues (7). More recent studies show that ipamorelin is able to promote collagen synthesis indirectly through elevated HGH and IGF-1, which leads to improved skin elasticity and accelerated wound healing (8).

GHRP-6 (Growth Hormone Releasing Peptide-6) similarly stimulates HGH secretion whilst also exhibiting anti-inflammatory properties. Research has shown that GHRP-6 can enhance collagen deposition in healing tissues and may protect against oxidative stress, a key contributor to premature ageing (9).

CJC-1295

CJC-1295 is a synthetic compound of growth hormone-releasing hormone (GHRH) that extends the half-life of naturally occurring GHRH, which results in sustained elevation of HGH levels (10). The prolonged HGH elevation translates to consistent collagen production, leading to improved skin texture and enhanced recovery from musculoskeletal injuries. 

Clinical observations show early indications that CJC-1295 may improve sleep quality; a critical factor for tissue repair and growth hormone pulsatility (11).

GHK-Cu: The Regenerative Copper Peptide

Whilst growth hormone and its secretagogues work systemically, GHK-Cu (glycyl-L-histidyl-L-lysine-copper) represents a different class of regenerative peptide with profound localised effects. This naturally occurring copper-binding peptide, first isolated from human plasma in the 1970s, has demonstrated remarkable tissue remodelling and regenerative properties (12).

Mechanisms of Action

GHK-Cu operates through multiple mechanisms simultaneously:

1. Collagen Stimulation: GHK-Cu upregulates collagen type I synthesis in fibroblasts whilst simultaneously modulating matrix metalloproteinases (MMPs), the specific enzymes that are responsible for collagen breakdown. This dual action creates an increase in dermal collagen density (13).
2. Antioxidant Properties: By chelating copper ions, GHK-Cu exhibits potent antioxidant effects, protecting cells from oxidative damage that accelerates ageing (14).
3. Gene Regulation: Perhaps most remarkably, GHK-Cu has been shown to reset gene expression patterns in aged human fibroblasts towards a more youthful state, affecting over 30% of genes related to oxidative stress, DNA repair, and tissue remodelling (15).

Clinical Applications

Topical application of GHK-Cu in the form of serums and creams is already FDA-approved and has demonstrated impressive results in clinical trials. A double-blind study found that creams containing GHK-Cu significantly improved the laxity, clarity, and overall appearance of participants’ skin after 12 weeks of use. These improvements are attributed to increased collagen and elastin synthesis (16). The peptide has also shown promise in accelerating wound healing and reducing scar formation through its influence on fibroblast migration and angiogenesis (17). 

Effects on Skin Elasticity and Appearance

The skin’s structural integrity relies predominantly on collagen, particularly types I and III, and elastin fibres within the dermal matrix. As we age, collagen production declines by approximately 1% annually after the age of 20, whilst collagenase activity (the enzyme that degrades collagen) increases (18).

Peptides combat this process through multiple pathways:

• Direct Collagen Synthesis: HGH, IGF-1, and GHK-Cu all stimulate fibroblast activity, increasing de novo collagen production (19).
• MMP Inhibition: GHK-Cu and certain growth factors modulate MMP expression, reducing excessive collagen degradation (20).
• Enhanced Hydration: Increased collagen density improves the skin’s ability to retain moisture, creating a plumper, more youthful appearance (21).

Clinical evidence suggests that peptide therapies can increase dermal thickness by 20-30% over several months, with corresponding improvements in fine lines, wrinkles, and skin texture (22).

Strengthening Hair: From Follicle to Strand

Hair loss and thinning represent common age-related concerns closely linked to declining growth hormone levels and reduced cellular regeneration in hair follicles. Peptides address hair health through several mechanisms:

Follicle Stimulation

HGH and IGF-1 are critical regulators of the hair growth cycle, promoting the transition from telogen (resting phase) to anagen (growth phase) (23). Growth hormone secretagogues that elevate systemic HGH levels may therefore extend the anagen phase, resulting in longer, thicker hair shafts.

Copper Peptides and Hair Regrowth

GHK-Cu has demonstrated specific benefits for hair regrowth. Studies indicate that copper peptides can increase hair follicle size, stimulate hair follicle cell proliferation, and inhibit the transformation of testosterone to dihydrotestosterone (DHT), a hormone implicated in androgenic alopecia (24). In one clinical trial, topical application of copper peptides increased hair density and thickness in individuals with thinning hair (25).

Structural Protein Enhancement

Peptides also strengthen the hair shaft itself by supporting keratin production, the structural protein comprising approximately 95% of hair composition. Enhanced collagen production in the scalp’s connective tissue provides better anchorage for follicles, reducing hair shedding (26).

Supporting Joint Health and Mobility

Joint degeneration, characterised by cartilage breakdown and inflammation, represents one of the most debilitating aspects of ageing. Peptides offer promising therapeutic potential for preserving and even regenerating joint structures.

Cartilage Regeneration

Articular cartilage, the smooth tissue covering joint surfaces, consists primarily of type II collagen and proteoglycans. HGH and IGF-1 stimulate chondrocyte proliferation and matrix synthesis, essential processes for cartilage maintenance and repair (27). Studies in patients with joint injuries have shown that growth hormone administration can accelerate cartilage healing and improve joint function (28).

Anti-Inflammatory Effects

Chronic low-grade inflammation, often termed “inflammaging”, contributes significantly to joint deterioration. Certain peptides, including GHRP-6 and BPC-157 (Body Protection Compound-157), exhibit anti-inflammatory properties that may protect joint tissues from inflammatory damage (29). By reducing pro-inflammatory cytokines such as IL-6 and TNF-α, these peptides create a more favourable environment for tissue repair (30).

Collagen Cross-Linking

Beyond simply increasing collagen quantity, peptides influence collagen quality through enhanced cross-linking, the chemical bonds that provide structural strength to collagen fibres. GHK-Cu, in particular, has been shown to improve collagen organisation and cross-linking patterns, resulting in more resilient connective tissue (31).

Safety Considerations and Future Directions

Whilst peptide therapies show tremendous promise, responsible use requires consideration of potential risks and individual variability. Growth hormone and secretagogues should be used under medical supervision, as excessive GH levels can lead to insulin resistance, joint pain, and other metabolic disturbances (32). Topical peptides like GHK-Cu generally demonstrate excellent safety profiles with minimal adverse effects (33).

Emerging research continues to unveil new peptide candidates with regenerative potential. Thymosin beta-4, epithalon, and various biomimetic peptides are currently under investigation for their anti-ageing and tissue repair properties (34). As our understanding of cellular signalling deepens, peptide-based therapies are likely to become increasingly sophisticated and personalised.

Final Thoughts on Peptides for Anti-Ageing

Peptides are changing the approach to anti-ageing. The injectable mechanism provides a precise way to interact with the body’s natural functions instead of opposing them. One example of this is HGH, a key hormone linked to anti-ageing, which drives the body’s renewal processes. As mentioned, GHK-Cu, a copper peptide that influences genetic activity to reset how cells function. These molecules act as effective tools to help maintain energy and youthfulness.

Peptides for anti-ageing have the potential to help the body fight ageing by increasing collagen, making skin firmer, strengthening hair, and improving joints. Instead of just covering up the signs of ageing, they target its root causes. As scientists learn more and explore new uses, peptides are expected to play a much bigger part in both anti-ageing treatments and regenerative health care.

 

You can take a look at our products for research purposes HERE.

 

Not all peptides in this article are FDA-approved for human use.

 

 

References for Peptides for Anti-Ageing

1. Bartke A. Growth hormone and ageing: updated review. World J Mens Health. 2019;37(1):19-30.
2. Iranmanesh A, Lizarralde G, Veldhuis JD. Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab. 1991;73(5):1081-8.
3. Rudman D, Feller AG, Nagraj HS, et al. Effects of human growth hormone in men over 60 years old. N Engl J Med. 1990;323(1):1-6.
4. Tavakkol A, Zouboulis CC, Duell EA, et al. Growth hormone receptor expression in human skin. J Invest Dermatol. 1992;99(3):342-9.
5. Madry H, Grun UW, Knutsen G. Cartilage repair and joint preservation: medical and surgical treatment options. Dtsch Arztebl Int. 2011;108(40):669-77.
6. Smith RG, Feighner S, Prendergast K, et al. A new orphan receptor involved in pulsatile growth hormone release. Trends Endocrinol Metab. 1999;10(4):128-35.
7. Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-61.
8. Svensson J, Lonn L, Jansson JO, et al. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure. J Clin Endocrinol Metab. 1998;83(2):362-9.
9. Berlanga-Acosta J, Gavilondo-Cowley J, López-Saura P, et al. Growth hormone releasing peptide 6 (GHRP6) reduces liver fibrosis in CCl4 chronically intoxicated rats. Biotecnol Apl. 2011;28(1):242-7.
10. Teichman SL, Neale A, Lawrence B, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analogue of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006;91(3):799-805.
11. Frieboes RM, Murck H, Maier P, et al. Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and cortisol release in normal man. Neuroendocrinology. 1995;61(5):584-9.
12. Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987.
13. Arul V, Kartha R, Jayakumar R. A therapeutic approach for diabetic wound healing using biotinylated GHK incorporated collagen matrices. Life Sci. 2007;80(4):275-84.
14. Lau KP, Li Y, Kam KW, et al. The copper peptide GHK-Cu promotes keratinocyte proliferation, epidermal barrier function, and the expression of extracellular matrix proteins. Wound Repair Regen. 2013;21(1):A28.
15. Pickart L, Vasquez-Soltero JM, Margolina A. The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health. Oxid Med Cell Longev. 2012;2012:324832.
16. Leyden J, Stephens T, Finkey MB, et al. Skin care benefits of copper peptide containing eye creams. Am Acad Dermatol. 2002;46:P219.
17. Siméon A, Wegrowski Y, Bontemps Y, Maquart FX. Expression of glycosaminoglycans and small proteoglycans in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu(2+). J Invest Dermatol. 2000;115(6):962-8.
18. Shuster S, Black MM, McVitie E. The influence of age and sex on skin thickness, skin collagen and density. Br J Dermatol. 1975;93(6):639-43.
19. Rittié L, Fisher GJ. Natural and sun-induced aging of human skin. Cold Spring Harb Perspect Med. 2015;5(1):a015370.
20. Ong CT, Khoo YT, Mukhopadhyay A, et al. mTOR as a potential therapeutic target for treatment of keloids and excessive scars. Exp Dermatol. 2007;16(5):394-404.
21. Gelse K, Pöschl E, Aigner T. Collagens—structure, function, and biosynthesis. Adv Drug Deliv Rev. 2003;55(12):1531-46.
22. Fabi S, Sundaram H. The potential of topical and injectable growth factors and cytokines for skin rejuvenation. Facial Plast Surg. 2014;30(2):157-71.
23. Philpott MP, Sanders DA, Kealey T. Effects of insulin and insulin-like growth factors on cultured human hair follicles: IGF-I at physiologic concentrations is an important regulator of hair follicle growth in vitro. J Invest Dermatol. 1994;102(6):857-61.
24. Pyo HK, Yoo HG, Won CH, et al. The effect of tripeptide-copper complex on human hair growth in vitro. Arch Pharm Res. 2007;30(7):834-9.
25. Uno H, Cappas A, Brigham P. Action of topical minoxidil in the bald stump-tailed macaque. J Am Acad Dermatol. 1987;16(3 Pt 2):657-68.
26. Kil IS, Lee SK, Ryu KW, et al. Feedback control of adrenal steroidogenesis by H2O2-dependent oxidation of the enzyme cytochrome P450 side-chain cleavage. J Biol Chem. 2012;287(12):9361-8.
27. Ohlsson C, Bengtsson BA, Isaksson OG, et al. Growth hormone and bone. Endocr Rev. 1998;19(1):55-79.
28. Christgau S, Henriksen DB, Tanko LB, et al. Suppression of elevated cartilage turnover in postmenopausal women and in ovariectomized rats by estrogen and a selective estrogen-receptor modulator (SERM). Menopause. 2004;11(5):508-18.
29. Seiwerth S, Rucman R, Turkovic B, et al. BPC 157 and blood vessels. Curr Pharm Des. 2014;20(7):1121-5.
30. Bertolini G, Roz L, Perego P, et al. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci U S A. 2009;106(38):16281-6.
31. Buffoni F, Pino R, Dal Pozzo A. Effect of tripeptide-copper complexes on the process of skin wound healing and on cultured fibroblasts. Arch Int Pharmacodyn Ther. 1995;330(2):266-80.
32. Leung KC, Johannsson G, Leong GM, Ho KK. Estrogen regulation of growth hormone action. Endocr Rev. 2004;25(5):693-721.
33. Hostynek JJ, Dreher F, Maibach HI. Human stratum corneum penetration by copper: in vivo study after occlusive and semi-occlusive application of the metal as powder. Food Chem Toxicol. 2006;44(9):1539-43.
34. Khavinson VKh, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med. 2003;135(6):590-2.

All references to support this blog ‘peptides for anti-ageing’ are available in PubMed